[exclusive] analysis of bidding trends in November 2018

In November, the centralized drug purchase documents of 4 + 7 cities became the focus of attention, and the involved cities were released on the official purchase platform The small edition still summarized the drug bidding dynamics of each province in this month (November) for reference (as of December 4): 1 The bidding dynamics of each province and city 2 Brief analysis of the centralized drug purchase documents of 4 + 7 cities that are worthy of attention this month The formal version of the previously well-known volume procurement document was released on November 15, 2018 There are 11 pilot cities for volume procurement, including 4 municipalities directly under the central government and 7 provincial capitals, involving 31 varieties The implementation of this policy is a huge impact on pharmaceutical enterprises, a test for pharmaceutical enterprises, and a test for decision-making departments Whether we can achieve win-win needs to be seen Other provinces worth noting are Shanxi and Sichuan On November 21, 2018, Shanxi Province publicized the dynamic linkage price information of drug procurement of public medical institutions in the whole province In total, 47 product specifications of different enterprises carried out this price linkage, including 14 base drugs and 33 non base drugs, all of which had different degrees of price reduction on the basis of the original bid price, with a maximum reduction of 33.9% On November 22, 2018, Sichuan Province issued a notice on the dynamic adjustment of 111 drugs such as tegio capsule There are 11 drugs involved in the adjustment, and the price limit for hanging the net was also lowered on the original price The largest drop was the tegio capsule of Qilu pharmaceutical The original price limit for hanging the net was 1011.88 yuan, and 491.4 yuan after dynamic adjustment If you need to know more about bidding dynamics, please remember to pay attention to our pharmaceutical intelligence bid database Data source: Yao Zhi data statement: This article only represents the author, not the position of Yao Zhi Com Welcome to exchange and supplement in the message area If you need to reprint, please be sure to indicate the author and source of the article.